Search Innovations in Heart Failure: Highlights and Insights From AHA 2021 LEARN MORE Get Smart: Leveraging New Technologies to Optimize Diabetes Management LEARN MORE 2021 Conference on Retroviruses and Opportunistic Infections LEARN MORE Latest Recommended Block View List View All Specialties All Topics All Content Types All Credit Types 12 of 4838 shown ClinicalThought IconClinicalThoughtHIV Cascade of HIV Care in Eastern Europe VIEW CLINICALTHOUGHT VIEW MORE ClinicalThought IconClinicalThoughtHepatitis Should We Screen All Patients With Hepatitis B for Hepatitis Delta? VIEW CLINICALTHOUGHT VIEW MORE ClinicalThought IconClinicalThoughtOncology Current Status of EGFR Tyrosine Kinase Inhibitor Combination Therapy in the Treatment of Newly Diagnosed EGFR-Mutated... VIEW CLINICALTHOUGHT VIEW MORE Multimedia IconMultimediaInfectious Disease Shingles in the COVID-19 Era: Increasing Shingles Vaccine UptakeCMECE VIEW MULTIMEDIA VIEW MORE Slideset IconSlidesetCardiology CHIEF-HF: Improvement in Heart Failure Symptoms at 12 Wk With Canagliflozin vs Placebo VIEW SLIDESET VIEW MORE Slideset IconSlidesetInfectious Disease Slides on Shingles in the COVID-19 Era: Increasing Shingles Vaccine Uptake VIEW SLIDESET VIEW MORE Multimedia IconMultimediaHepatitis Key Viral Hepatitis Studies Influencing My Practice Following AASLD 2021 – Dr. Nancy Reau VIEW MULTIMEDIA VIEW MORE Slideset IconSlidesetCardiology EMPEROR-Preserved: Primary Endpoint and Key Quality of Life Results With Empagliflozin vs Placebo in Patients With LVEF ≥50% VIEW SLIDESET VIEW MORE Slideset IconSlidesetCardiology Cardiac Imaging Key to Detecting Early Relapse After Withdrawal of Heart Failure Medications in Patients In Remission VIEW SLIDESET VIEW MORE Slideset IconSlidesetInternal Medicine Cardiac Imaging Key to Detecting Early Relapse After Withdrawal of Heart Failure Medications in Patients In Remission VIEW SLIDESET VIEW MORE Slideset IconSlidesetInternal Medicine EMPEROR-Preserved: Primary Endpoint and Key Quality of Life Results With Empagliflozin vs Placebo in Patients With LVEF ≥50% VIEW SLIDESET VIEW MORE Slideset IconSlidesetOncology Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective VIEW SLIDESET VIEW MORE 12 of 4838 shown Show 12 More Live Events HIV Neurology-Psychiatry Oncology Oncology FIND EVENTS NEAR ME A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE A Review of Current and Emerging Treatment Options for Myelodysplastic Syndromes 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Acute Myeloid Leukemia: Evidence-Based Guidance on Current Paradigms and New Therapeutic Approaches 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Addressing Clinical Challenges in T-Cell Lymphomas Through Biomarker-Driven Therapy 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Advances in CAR T-Cell Therapy Across Hematologic Malignancies: From Pipeline to Clinical Practice 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Advances in Immune Thrombocytopenia: Expert Guidance to Navigate an Evolving Therapeutic Landscape 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Applying Guideline Updates and Real-World Experience in CLL 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Asparaginase-Based Therapy in Young and Older Adults With ALL: Leveraging the Pediatric Experience 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE aTTP: Clinical Application of Precision Medicine and New Guidelines 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Caring for Patients With Hemophilia A in the Midst of a Therapeutic Revolution 2 UPCOMING EVENTS, BEGINNING 12/10/2021 LEARN MORE Adopting New Approaches in AL Amyloidosis: Expert Perspectives on Latest Evidence 1 UPCOMING EVENT, ON 1/11/2022 LEARN MORE Acute and Chronic GVHD: Current Approaches, Near-Term Progress, and Future Directions 1 UPCOMING EVENT, ON 1/27/2022 LEARN MORE Changing the Course of Outcomes in NSCLC: Immunotherapy Approaches for Early-Stage Disease 2 UPCOMING EVENTS, BEGINNING 12/13/2021 LEARN MORE Chronic Lymphocytic Leukemia: Applying the Latest Data in Community Practice 1 UPCOMING EVENT, ON 12/29/2021 LEARN MORE Personalize your Recommended Content Settings Immediate answers to patient care questions HepatologyLatest News New information on HCV prevalence, treatment, and management of reinfection among persons who inject drugs Updated to reflect that no dose adjustments are required for any recommended DAA regimen for patients with severe renal impairment See All HepatologyLatest News New information on HCV prevalence, treatment, and management of reinfection among persons who inject drugs Updated to reflect that no dose adjustments are required for any recommended DAA regimen for patients with severe renal impairment See All HIVLatest News Addition of information from the National Comprehensive Cancer Network’s guideline on Cancer in People With HIV Information on incidence of NADCs in people with HIV compared with people who do not have HIV from NA-ACCORD See All HIVLatest News Addition of information from the National Comprehensive Cancer Network’s guideline on Cancer in People With HIV Information on incidence of NADCs in people with HIV compared with people who do not have HIV from NA-ACCORD See All User Resources My Profile Contact Us Help Site Requirements Privacy Policy Terms of Use Specialty Sites Cardiology Endocrinology Health Disparities Hepatitis HIV Immunology Infectious Disease Internal Medicine Neurology/Psychiatry Oncology Pulmonology Other CCO Sites CCO inPractice About CCO Careers Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials. © 2021 Clinical Care Options, LLC. All rights reserved. Cookie Preferences Live chat: Chat with an Agent